1. Home
  2. BCYC vs BLW Comparison

BCYC vs BLW Comparison

Compare BCYC & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • BLW
  • Stock Information
  • Founded
  • BCYC 2009
  • BLW 2003
  • Country
  • BCYC United Kingdom
  • BLW United States
  • Employees
  • BCYC N/A
  • BLW N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • BLW Other Consumer Services
  • Sector
  • BCYC Health Care
  • BLW Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • BLW Nasdaq
  • Market Cap
  • BCYC 620.7M
  • BLW 506.7M
  • IPO Year
  • BCYC 2019
  • BLW N/A
  • Fundamental
  • Price
  • BCYC $8.56
  • BLW $13.95
  • Analyst Decision
  • BCYC Buy
  • BLW
  • Analyst Count
  • BCYC 8
  • BLW 0
  • Target Price
  • BCYC $29.14
  • BLW N/A
  • AVG Volume (30 Days)
  • BCYC 331.4K
  • BLW 85.9K
  • Earning Date
  • BCYC 05-01-2025
  • BLW 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • BLW 8.83%
  • EPS Growth
  • BCYC N/A
  • BLW N/A
  • EPS
  • BCYC N/A
  • BLW 1.81
  • Revenue
  • BCYC $35,275,000.00
  • BLW N/A
  • Revenue This Year
  • BCYC N/A
  • BLW N/A
  • Revenue Next Year
  • BCYC $18.29
  • BLW N/A
  • P/E Ratio
  • BCYC N/A
  • BLW $7.73
  • Revenue Growth
  • BCYC 30.76
  • BLW N/A
  • 52 Week Low
  • BCYC $8.20
  • BLW $12.35
  • 52 Week High
  • BCYC $28.67
  • BLW $14.26
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 29.39
  • BLW 34.84
  • Support Level
  • BCYC $8.60
  • BLW $13.91
  • Resistance Level
  • BCYC $9.69
  • BLW $14.08
  • Average True Range (ATR)
  • BCYC 0.67
  • BLW 0.10
  • MACD
  • BCYC 0.00
  • BLW -0.01
  • Stochastic Oscillator
  • BCYC 6.05
  • BLW 11.35

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About BLW Blackrock Limited Duration Income Trust

Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: